Introducing CM3 HMB Fusion – 200 caps
Take your training to the next level with CM3 HMB Fusion – 200 caps from Trec Nutrition. This powerful supplement is designed to support muscle growth and recovery, making it an essential addition to any athlete or fitness enthusiast’s routine.
Properties:
- Contains 200 capsules per bottle
- Each capsule contains 1000mg of Creatine Malate (CM3) and 500mg of HMB
- Provides a potent combination of two powerful ingredients for muscle growth and recovery
- Easy to swallow capsules for convenient consumption
Ingredients:
CM3 HMB Fusion – 200 caps contains a unique blend of two key ingredients:
Ingredient | Amount per capsule |
---|---|
Creatine Malate (CM3) | 1000mg |
HMB | 500mg |
Creatine Malate (CM3) is a highly bioavailable form of creatine, which is essential for energy production in the muscles. HMB, or beta-hydroxy beta-methylbutyrate, is a metabolite of the amino acid leucine and has been shown to support muscle growth and recovery.
Benefits:
CM3 HMB Fusion – 200 caps offers a range of benefits for athletes and fitness enthusiasts:
- Supports muscle growth and recovery
- Enhances strength and endurance
- Improves overall athletic performance
- Reduces muscle breakdown during intense training
- Increases muscle mass and definition
Features:
CM3 HMB Fusion – 200 caps is a high-quality supplement that stands out for its unique features:
- Manufactured by Trec Nutrition, a trusted brand in the fitness industry
- Made in Poland, ensuring high-quality ingredients and production standards
- Contains a potent combination of CM3 and HMB for maximum effectiveness
- Easy to swallow capsules for convenient consumption
- Free from fillers, additives, and artificial ingredients
Take your training to the next level with CM3 HMB Fusion – 200 caps from Trec Nutrition. With its powerful blend of ingredients, this supplement is the perfect addition to your fitness routine for optimal muscle growth and recovery. Order now and experience the benefits for yourself!
Reviews
There are no reviews yet.